Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
11/08/202221:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
11/08/202213:00GlobeNewswire Inc.Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022NASDAQ:SMMTSummit Therapeutics Inc
09/08/202220:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
09/08/202218:37GlobeNewswire Inc.Summit Therapeutics Closes Fully-Subscribed $100 Million Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
02/08/202214:25GlobeNewswire Inc.Summit Therapeutics’ Rights Offering Nearing Expiration DateNASDAQ:SMMTSummit Therapeutics Inc
26/07/202221:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
26/07/202221:15GlobeNewswire Inc.Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO & PresidentNASDAQ:SMMTSummit Therapeutics Inc
18/07/202221:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
18/07/202221:05GlobeNewswire Inc.Summit Therapeutics Announces Commencement of $100 Million Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
18/07/202220:50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SMMTSummit Therapeutics Inc
14/07/202213:30GlobeNewswire Inc.Summit Therapeutics Provides Update on RidinilazoleNASDAQ:SMMTSummit Therapeutics Inc
07/07/202215:26Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SMMTSummit Therapeutics Inc
22/06/202221:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
22/06/202221:30GlobeNewswire Inc.Summit Therapeutics Announces $100 Million Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
03/06/202221:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SMMTSummit Therapeutics Inc
03/06/202213:30GlobeNewswire Inc.Summit Therapeutics’ Upcoming Annual Shareholders’ MeetingNASDAQ:SMMTSummit Therapeutics Inc
02/06/202222:39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SMMTSummit Therapeutics Inc
01/06/202221:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
01/06/202213:30GlobeNewswire Inc.Summit Therapeutics Appoints Ankur Dhingra as Chief Financial OfficerNASDAQ:SMMTSummit Therapeutics Inc
11/05/202221:51Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
11/05/202221:30GlobeNewswire Inc.Summit Therapeutics Inc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2022NASDAQ:SMMTSummit Therapeutics Inc
29/04/202221:56Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SMMTSummit Therapeutics Inc
26/04/202221:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
14/04/202221:13Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
06/04/202222:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SMMTSummit Therapeutics Inc
17/03/202221:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SMMTSummit Therapeutics Inc
17/03/202220:25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
17/03/202220:14GlobeNewswire Inc.Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021NASDAQ:SMMTSummit Therapeutics Inc
11/03/202221:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
09/02/202222:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT